Preclinical evaluation of immunogenicity, efficacy and safety of a recombinant plant-based SARS-CoV-2 RBD vaccine formulated with 3M-052-Alum adjuvant

Waranyoo Phoolcharoen, Balamurugan Shanmugaraj, Narach Khorattanakulchai, Piyanate Sunyakumthorn, Sathit Pichyangkul, Pornnarin Taepavarapruk, Wanlapa Praserthsee, Suchinda Malaivijitnond, Suwimon Manopwisedjaroen, Arunee Thitithanyanont, Kanjana Srisutthisamphan, Anan Jongkaewwattana, Mark Tomai, Christopher B. Fox, Suthira Taychakhoonavudh

Open source

DOI: 10.1016/j.vaccine.2023.03.027
Published: 2023-04
Container: Vaccine
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.vaccine.2023.03.027,
  title = {Preclinical evaluation of immunogenicity, efficacy and safety of a recombinant plant-based SARS-CoV-2 RBD vaccine formulated with 3M-052-Alum adjuvant},
  author = {Waranyoo Phoolcharoen and Balamurugan Shanmugaraj and Narach Khorattanakulchai and Piyanate Sunyakumthorn and Sathit Pichyangkul and Pornnarin Taepavarapruk and Wanlapa Praserthsee and Suchinda Malaivijitnond and Suwimon Manopwisedjaroen and Arunee Thitithanyanont and Kanjana Srisutthisamphan and Anan Jongkaewwattana and Mark Tomai and Christopher B. Fox and Suthira Taychakhoonavudh},
  year = {2023},
  journal = {Vaccine},
  doi = {10.1016/j.vaccine.2023.03.027},
  url = {https://doi.org/10.1016/j.vaccine.2023.03.027}
}

RIS

TY  - JOUR
TI  - Preclinical evaluation of immunogenicity, efficacy and safety of a recombinant plant-based SARS-CoV-2 RBD vaccine formulated with 3M-052-Alum adjuvant
AU  - Waranyoo Phoolcharoen
AU  - Balamurugan Shanmugaraj
AU  - Narach Khorattanakulchai
AU  - Piyanate Sunyakumthorn
AU  - Sathit Pichyangkul
AU  - Pornnarin Taepavarapruk
AU  - Wanlapa Praserthsee
AU  - Suchinda Malaivijitnond
AU  - Suwimon Manopwisedjaroen
AU  - Arunee Thitithanyanont
AU  - Kanjana Srisutthisamphan
AU  - Anan Jongkaewwattana
AU  - Mark Tomai
AU  - Christopher B. Fox
AU  - Suthira Taychakhoonavudh
PY  - 2023
JO  - Vaccine
DO  - 10.1016/j.vaccine.2023.03.027
UR  - https://doi.org/10.1016/j.vaccine.2023.03.027
ER  -

APA

Phoolcharoen, W., Shanmugaraj, B., Khorattanakulchai, N., Sunyakumthorn, P., Pichyangkul, S., Taepavarapruk, P., Praserthsee, W., Malaivijitnond, S., Manopwisedjaroen, S., Thitithanyanont, A., Srisutthisamphan, K., Jongkaewwattana, A., Tomai, M., Fox, C. B., & Taychakhoonavudh, S. (2023). Preclinical evaluation of immunogenicity, efficacy and safety of a recombinant plant-based SARS-CoV-2 RBD vaccine formulated with 3M-052-Alum adjuvant. Vaccine. https://doi.org/10.1016/j.vaccine.2023.03.027

Source records

crossref · retrieved 2026-09-27T15:11:24.422Z